Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
21 Feb 2015 - 26 Feb 2015
February 21-26, 2015: Â GenSight attended NANOS
12 Jan 2015 - 16 Jan 2015
January 12-16, 2015: GenSight presented at the 33rd Annual J.P. Morgan Healthcare Conference, San Francisco (CA),
03 Dec 2014
December 3, 2014: Didier Pruneau, CSO of GenSight, featured at Gene Therapy
19 Nov 2014 - 21 Nov 2014
November 19-21, 2014 : GenSight presented at Therapeutic Area Partnership,
23 Jun 2014 - 26 Jun 2014
June 23-26, 2014: GenSight Biologics attended BIO, San Diego, CA, USA
06 Jun 2014
June 6, 2014: GenSight Biologics won the award of the Investor Conference
21 May 2014 - 22 May 2014
May 21-22, 2014: GenSight Biologics presented in the the Next wave Companies
04 May 2014 - 09 May 2014
May 4-9, 2014: GenSight Biologics attended ARVO annual meeting, Orlando, FL, USA
10 Mar 2014 - 12 Mar 2014
March 10-12, 2014: GenSight Biologics presented at BioEurope Spring
28 Feb 2014
February 28, 2014: GenSight Biologics expands its Series A round to the French seed fund
View previous 9 articles
1
…
11
12
13
14
15
16
17
View next 9 articles
Go back to the page of the page